Oncolytic viruses get a boost with first FDA-approval recommendation
Elie Dolgin • June 1, 2015
The future of cancer-killing viruses lies in their potential to augment cell and antibody immunotherapies.
Continue reading here.
With a call of 130 decibels, the bare-throated bellbird is a big-beaked marvel.
Autonomous blood-drawing devices could help address phlebotomist shortages.